What does PHARMACTION do?

PHARMACTION is an advertising agency in Vorst. Private Limited, started on 15 February 2017, 1 establishment.

What is the address of PHARMACTION?

The registered office of PHARMACTION is located at Berthelotstraat 106 box 31, 1190 Vorst.

Is PHARMACTION still active?

Yes. According to the CBE (29 October 2026) PHARMACTION is active, legal situation “Normale toestand”, started on 15 February 2017.

Is PHARMACTION registered on Peppol?

Yes, PHARMACTION is registered on the Peppol network with ID 0208:0671515855.

What is the enterprise number of PHARMACTION?

The enterprise number of PHARMACTION is BE0671515855.

When was PHARMACTION founded?

PHARMACTION was founded on 15 February 2017.

Who are the directors of PHARMACTION?

According to the 2025 annual accounts, the directors of PHARMACTION are: Marc Puissant Baeyens, Sébastien Colin.

Is PHARMACTION a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 February 2017; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACTION make in 2025?

PHARMACTION posted a profit after taxes of € 19,582 in financial year 2025.

What is the revenue of PHARMACTION?

As a small company, PHARMACTION is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 28,360.

PHARMACTION (Private Limited) - Vorst - BE0671515855

Dossier PHARMACTION, printed on 29 October 2026 from databakkes.be/en/0671515855/pharmaction. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACTION from Vorst, company number BE0671515855, closed financial year 2025 with a result of € 19,582 after tax. For that financial year PHARMACTION recorded a gross margin of € 28,360 and equity of € 86,954. Compared with financial year 2024, the result moved from € 15,835 to € 19,582. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on November 30, 2025.

What it is worth Growing

€ 86,954

▲ 29% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 19,582

▲ 24% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 5,916

▼ 80% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 66,549.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 188,147

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,348

▲ 29% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 18,911 Gross margin 2022: € 18,911 First fiscal year in the series	€ 18,890 Gross margin 2023: € 18,890 Unchanged (€ 18,911) Unfavourable step	€ 22,478 Gross margin 2024: € 22,478 ▲ 19% vs 2023 (€ 18,890) Favourable step	€ 28,360 Gross margin 2025: € 28,360 ▲ 26% vs 2024 (€ 22,478) Favourable step	▲ 26%
Profit after taxes	€ 9,363 Profit after taxes 2022: € 9,363 First fiscal year in the series	€ 13,762 Profit after taxes 2023: € 13,762 ▲ 47% vs 2022 (€ 9,363) Favourable step	€ 15,835 Profit after taxes 2024: € 15,835 ▲ 15% vs 2023 (€ 13,762) Favourable step	€ 19,582 Profit after taxes 2025: € 19,582 ▲ 24% vs 2024 (€ 15,835) Favourable step	▲ 24%
Equity	€ 37,775 Equity 2022: € 37,775 First fiscal year in the series	€ 51,537 Equity 2023: € 51,537 ▲ 36% vs 2022 (€ 37,775) Favourable step	€ 67,373 Equity 2024: € 67,373 ▲ 31% vs 2023 (€ 51,537) Favourable step	€ 86,954 Equity 2025: € 86,954 ▲ 29% vs 2024 (€ 67,373) Favourable step	▲ 29%
Total debts	€ 61,296 Total debts 2022: € 61,296 First fiscal year in the series	€ 123,542 Total debts 2023: € 123,542 ▲ 102% vs 2022 (€ 61,296) Unfavourable step	€ 204,058 Total debts 2024: € 204,058 ▲ 65% vs 2023 (€ 123,542) Unfavourable step	€ 203,918 Total debts 2025: € 203,918 Unchanged (€ 204,058) Favourable step
Cash	€ 27,795 Cash 2022: € 27,795 First fiscal year in the series	€ 12,462 Cash 2023: € 12,462 ▼ 55% vs 2022 (€ 27,795) Unfavourable step	€ 29,904 Cash 2024: € 29,904 ▲ 140% vs 2023 (€ 12,462) Favourable step	€ 5,916 Cash 2025: € 5,916 ▼ 80% vs 2024 (€ 29,904) Unfavourable step	▼ 80%
Retained profit	€ 19,225 Retained profit 2022: € 19,225 First fiscal year in the series	€ 32,987 Retained profit 2023: € 32,987 ▲ 72% vs 2022 (€ 19,225) Favourable step	€ 46,968 Retained profit 2024: € 46,968 ▲ 42% vs 2023 (€ 32,987) Favourable step	€ 66,549 Retained profit 2025: € 66,549 ▲ 42% vs 2024 (€ 46,968) Favourable step	▲ 42%
Balance sheet total	€ 99,071 Balance sheet total 2022: € 99,071 First fiscal year in the series	€ 175,079 Balance sheet total 2023: € 175,079 ▲ 77% vs 2022 (€ 99,071) Unchanged	€ 271,430 Balance sheet total 2024: € 271,430 ▲ 55% vs 2023 (€ 175,079) Unchanged	€ 290,873 Balance sheet total 2025: € 290,873 ▲ 7% vs 2024 (€ 271,430) Unchanged	▲ 7%

Key figures of PHARMACTION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to PHARMACTION?

What happened at PHARMACTION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Nov 30, 2025 New annual accounts for financial year 2025: profit of € 19,582 (▲ 24% vs 2024). Source: NBB ↗
Feb 15, 2017 New establishment in Vorst. KBO
Feb 15, 2017 Start of the company according to the CBE. KBO

In short

From € 9,363 profit in 2022 to € 19,582 profit in 2025.

Paid € 20,814 in corporate taxes since 2022.

Best year ever: 2025, with € 19,582 profit.

Original PDFs at the National Bank ↗

Management

PROFIELD 30%

The stake of PROFIELD comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACTION

Behind PHARMACTION are Marc Puissant Baeyens and Sébastien Colin. The shares are held by PROFIELD (30%).

Directors

According to the 2025 annual accounts

Marc Puissant Baeyens

Director

Also active at: AROUND COMMUNICATIONS, MPB COMPANY, PROFIELD

Sébastien Colin

Director

Shareholders

PROFIELD

30%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Berthelotstraat 106 box 31

1190 Vorst

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Bromophoto

Club Tonnerre

€ 134,394 gross margin · 2025

BO AND BOWL

€ 327,250 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0671.515.855

VAT number

BE 0671.515.855

Registered office

Berthelotstraat 106 bus 31, 1190 Vorst

Names & denominations

PHARMACTION

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 February 2017

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Activiteiten van reclamebureaus

Activiteiten van callcenters

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACTION

Financials

What happened to PHARMACTION?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions